Showing results (131-140 of 167) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal CancerAmir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastasesDan G Blazer, Yoji Kishi, Dipen M Maru, et al.Annals of Surgery|July 18, 2020
Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive ChemoradiationKazuto Harada, Carol C Wu, Xuemei Wang, et al.Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancerKazuki Sudo, Lianchun Xiao, Roopma Wadhwa, et al.Molecular Oncology|November 12, 2013
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patientsJ A Ajani, X Wang, S Song, et al.Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.The Annals of Thoracic Surgery|August 25, 2010
Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan statusMin P Kim, Arlene M Correa, Jared Lee, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinomaTakashi Taketa, Kazuki Sudo, Arlene M Correa, et al.Cancer|September 9, 2017
Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experienceMariela Blum Murphy, Lianchum Xiao, Viren R Patel, et al.Pageof 17